• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

PropThink: Interim Data In Spinal Cord Injury Driving STEM Higher; PSTI Reacting in Sympathy

September 4, 2012 By SPINEMarketGroup

This morning, StemCells, Inc. (NASDAQ:STEM) released six-month interim results for the first group of patients in its Phase I/II trial, testing the company’s HuCNS-SC (human neural stem cells) treatment candidate in patients with spinal cord injury – previous coverage available here. Shares are trading up nearly 20% in pre-market, and are likely to maintain momentum on the positive news. The interim data showed that thus far, HuCNS-SC treatment led to considerable gains in sensory function in two of three patients vs. their baseline levels of sensation prior to cell transplantation. The company also noted that the treatment continues to exhibit a favorable safety profile. The trial represents the first time that neural stem cells have been transplanted as a potential therapeutic agent for spinal cord injury, and the sensory gains observed have developed in a progressive pattern below the level of injury. Impressively, gains in sensation are not generally expected in spinal cord injury patients, particularly given the severity of injury seen in patients admitted to the Phase I/II study. According to STEM, sensory function of all patients observed thus far was stable before cell transplantation, therefore, the reappearance of sensation is a very positive sign that the treatment is having a beneficial effect. While the third patient did not experience an increase in sensation, that patient’s level of sensation remains stable. PropThink notes that another small-cap stem cell company, PluriStem Therapeutics (NASDAQ:PSTI) is also moving in pre-market trading, likely in sympathy with the STEM news.
To see this article at PropThink.com, click here.
About PropThink
PropThink is an intelligence service that delivers long and short trading ideas to investors in the healthcare and life sciences sectors. Our focus is on identifying and analyzing technically-complicated companies and equities that are grossly over or under-valued. We offer daily market coverage, weekly feature stories, and a newsletter to investors who subscribe on PropThink.com. To learn more visit us athttp://www.propthink.com.

(Visited 3 times, 1 visits today)

Filed Under: 2012, NEWS, OLD ARCHIVES Tagged With: 2012

Reader Interactions

Comments

  1. Tom Jones says

    November 8, 2015 at 3:17 pm

    James D. Wilkerson, Jr., P. A. provides specialized representation to victims who have suffered serious injuries or have lost a loved one due to an accident that was caused by someone else’s carelessness. They have been representing accident victims for over twenty five years. Mr. Wilkerson is Board Certified Civil Trial Attorney and for over twenty years has been recognized as possessing the highest rating for skill and ethics by the nationally recognized attorney rating organization Martindale-Hubbell. He is a Life Member of the Million Dollar Advocates Forum which recognizes attorneys have made recoveries for their clients of at least one million dollars. Mr. Wilkerson has also been recognized as one of the Top 100 trial lawyers in Florida by the National Trial Lawyers Association. If a serious injury or wrongful death occurs, he can serve your needs in the following types of cases: vehicle crash attorney, car accident lawyer, boating accident attorney, slip and fall attorney on premises, your attorney because of other dangerous conditions on property, dog bite attorney or nursing home neglect lawyer. His firm’s office is conveniently located in West Palm Beach, Florida and has the experience to provide competent individualized representation. For more information or to schedule a free initial consultation, call (561) 682-9060 or visit http://www.pbcinjuryattorney.com

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • Just Reflective, Not Disappointed: Globus Medical’s…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • What’s Happening with Globus Medical? Why Has the…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • Why Didn’t Globus Medical’s Stock Rise After…
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • Globus Medical to Execute $500 Million Share Buyback…
  • Globus Medical extends versatility of Advanced…
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Dispute Over Spinal Implant Royalties Between…
  • M6 Discontinued: What Are the Alternatives for a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Stryker’s Spine Exit: What It Means for…
  • Globus Medical Reports First Quarter 2025 Results
  • Has Globus Already Surpassed Medtronic in the Spine…
  • Viscogliosi Brothers Completes Acquisition of U.S.…
  • LAST 10 VIDEOS PUBLISHED

    1. Biedermann Motech: MOSS 100 (Short)
    2. POWEHI MEDICAL AG: KUDOS™ Modular
    3. POWEHI MEDICAL AG: TANTO® Screw
    4. Syntropiq: Taurus TLIF (Short)
    5. LEM Surgical: Dynamis Surgical Robot
    6. Aegis Spine:PathLoc-TA
    7. NGMedical: MOVE®-C Artificial Disc
    8. B.Braun Aesculap: Ennovate® Cervical MIS
    9. Spineart: PERLA® TL Deformity Solutions
    10. NGMedical: MOVE®-C

    Recent Comments

    • Peter on A New Player in Spinal Care, POWEHI Medical!
    • Sandy on Just Reflective, Not Disappointed: Globus Medical’s Bittersweet Q1 2025
    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}